指南与共识卫生政策与健康促进传染病防控与疫情报告

制定基于证据的指标以监测欧盟/欧洲经济区国家的HIV暴露前预防规划:多利益相关方共识

Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus.
指南 / 共识 · Euro Surveill · 2023-01-01

2016至2023年间,欧盟和欧洲经济区多国建立并扩大HIV暴露前预防(PrEP)规划,但缺乏统一定义的常规监测指标以实现最低可比性。本文基于系统性、证据知情的共识构建过程,提出一套结构化于改编版PrEP照护连续体的指标,按专家共识程度分为核心、补充和可选指标,以协调监测欧洲PrEP规划的实施与影响。

要点

  • 提出一套结构化于PrEP照护连续体的协调监测指标框架。
  • 指标按专家共识程度分为核心、补充和可选三个优先级。
  • 该框架旨在评估PrEP对欧洲HIV流行的影响。

核心结论

  • 该监测框架结合标准化方法与适应性及补充研究的机会,将有助于评估PrEP对欧洲HIV流行的影响。

研究设计与样本

  • 采用系统性、证据知情的共识构建过程,涉及广泛的多学科专家小组。

主要发现

  • 提出一套结构化于改编版PrEP照护连续体相关步骤的指标集。
  • 根据专家小组共识程度对指标进行优先级划分。
  • 区分欧盟/欧洲经济区任何PrEP规划均视为必要的「核心」指标与「补充」和「可选」指标,后者提供有意义数据但专家评估其数据收集和报告的可行性高度依赖具体情境。

关键数值与推荐

  • 核心指标被视为欧盟/欧洲经济区任何PrEP规划的必要指标。
  • 补充和可选指标提供有意义数据,但其数据收集和报告的可行性被专家评估为高度依赖具体情境。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several countries in the European Union (EU) and European Economic Area (EEA) established and/or scaled up HIV pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes' performance and effectiveness in reaching those most in need will be needed to assess regional progress in the roll-out of PrEP. However, there is a lack of commonly defined indicators for routine monitoring to allow for minimum comparability. We propose a harmonised PrEP monitoring approach for the EU/EEA, based on a systematic and evidence-informed consensus-building process involving a broad and multidisciplinary expert panel. We present a set of indicators, structured along relevant steps of an adapted PrEP care continuum, and offer a prioritisation based on the degree of consensus among the expert panel. We distinguish between 'core' indicators deemed essential for any PrEP programme in the EU/EEA, vs 'supplementary' and 'optional' indicators that provide meaningful data, yet where experts evaluated their feasibility for data collection and reporting as very context-dependent. By combining a standardised approach with strategic opportunities for adaptation and complementary research, this monitoring framework will contribute to assess the impact of PrEP on the HIV epidemic in Europe.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Vanhamel J, Wijstma E, Deblonde J, et al. Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus. Euro Surveill. 2023. PMID: 37289428. doi:10.2807/1560-7917.ES.2023.28.23.2200546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。